About this Journal Submit a Manuscript Table of Contents
Advances in Pharmacological Sciences
Volume 2014 (2014), Article ID 981624, 7 pages
Clinical Study

Simple and Robust Analysis of Cefuroxime in Human Plasma by LC-MS/MS: Application to a Bioequivalence Study

Research Center for Clinical Pharmacy, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, Zhejiang University, Qingchun Road 79, Hangzhou 310003, China

Received 11 January 2014; Revised 26 March 2014; Accepted 1 April 2014; Published 24 April 2014

Academic Editor: Brian R. Overholser

Copyright © 2014 Xingjiang Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. Foord, “Cefuroxime: human pharmacokinetics,” Antimicrobial Agents and Chemotherapy, vol. 9, no. 5, pp. 741–747, 1976. View at Scopus
  2. S. M. Harding, P. E. O. Williams, and J. Ayrton, “Pharmacology of cefuroxime as the 1-acetoxyethyl ester in volunteers,” Antimicrobial Agents and Chemotherapy, vol. 25, no. 1, pp. 78–82, 1984. View at Scopus
  3. A. Finn, A. Straughn, M. Meyer, and J. Chubb, “Effect of dose and food on the bioavailability of cefuroxime axetil,” Biopharmaceutics and Drug Disposition, vol. 8, no. 6, pp. 519–526, 1987. View at Scopus
  4. R. Denooz and C. Charlier, “Simultaneous determination of five β-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 864, no. 1-2, pp. 161–167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Partani, S. Gurule, A. Khuroo, T. Monif, and S. Bhardwaj, “Liquid chromatography/electrospray tandem mass spectrometry method for the determination of cefuroxime in human plasma: Application to a pharmacokinetic study,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 878, no. 3-4, pp. 428–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Colin, L. D. Bock, H. Tjollyn, et al., “Development and validation of a fast and uniform approach to quantify beta-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry,” Talanta, vol. 103, pp. 285–293, 2013.
  7. J. B. Bulitta, C. B. Landersdorfer, M. Kinzig, U. Holzgrabe, and F. Sorgel, “New semiphysiological absorption model to assess the pharmacodynamic profile of cefuroxime axetil using nonparametric and parametric population pharmacokinetics,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 8, pp. 3462–3471, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Carlier, V. Stove, J. A. Roberts, et al., “Quantification of seven beta-lactam antibiotics and two beta-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method,” International Journal of Antimicrobial Agents, vol. 40, no. 5, pp. 416–422, 2012.
  9. F. Wolff, G. Deprez, L. Seyler, et al., “Rapid quantification of six beta-lactams to optimize dosage regimens in severely septic patients,” Talanta, vol. 103, pp. 153–160, 2013.
  10. A. Viberg, M. Sandström, and B. Jansson, “Determination of cefuroxime in human serum or plasma by liquid chromatography with electrospray tandem mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 18, no. 6, pp. 707–710, 2004. View at Scopus
  11. L. Novakova, “Challenges in the development of bioanalytical liquid chromatography-mass spectrometry method with emphasis on fast analysis,” Journal of Chromatography A, vol. 1292, pp. 25–37, 2013.
  12. FDA Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), 2001, http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070107.pdf.
  13. China Food and Drug Administration, Center for Drug Evaluation, “Guideline for bioavailability and bioequivalence studies of generic drug products,” 2009 (Chinese), http://www.sfda.gov.cn/directory/web/WS01/images/u6Rp9KpzuWxrzByMvM5cn6zuA+9PDtsi6zcn6zu+1yNCn0NTR0L6vLzK9da4tbzUrdTyLnBkZg==.pdf.